Advent to sell German pharmaceutical group Viatris to Meda | AltAssets Private Equity News

Subscribe today

Advanced
Search

Advent to sell German pharmaceutical group Viatris to Meda

10 Aug 2005

Advent International has agreed to sell German pharmaceutical group Viatris to Swedish specialty pharma company Meda for €750m.

Sorry, to read the full story you must be a Premium Subscriber

Are you a subscriber?

In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.

Become a Premium Subscriber
for only £150 / €180 / $225 p.a.

Login area

If you are already a AltAssets subscriber please log in below.